A fresh flu vaccine built with the same mRNA tech that helped stop COVID‑19 is getting a green light from U. S. health experts. The FDA’s panel said the benefits outweigh the risks for people aged 50 to 64, and it will also consider using it in those 65 and older while more tests are done. The va
About fifteen years ago, doctors noticed something strange. People who got bitten by ticks were suddenly having bad reactions to meat. This allergy is called alpha-gal syndrome. It happens when a sugar called alpha-gal gets into the body. The sugar is found in mammal meat and sometimes in tick spit.
The U. S. Food and Drug Administration has cleared a new artificial‑intelligence system that can spot sepsis much faster than clinicians normally do. Developed by researchers at Johns Hopkins University, the software scans patients’ electronic health records and flags possible infection signs up to
The buzz around ibogaine, a plant‑derived drug from West Africa, exploded when a U. S. president highlighted its promise at a White House event that celebrated psychedelic research. For the first time, the Food and Drug Administration has cleared a clinical trial to test the substance in people.
Doctors in the U. S. now have another tool to fight a tough cancer. The FDA gave the green light for early use of an experimental pill called daraxonrasib. It targets pancreatic ductal adenocarcinoma, a fast-spreading form of pancreatic cancer that has already resisted other treatments. Patients who
Dog owners in the U. S. might soon have a new tool to help their aging pets live healthier, longer lives. A California-based company is testing a drug called LOY-002, designed to slow down aging in dogs. Unlike typical medications that treat specific diseases like arthritis or cancer, this pill aims
A new link between sleep-tracking gadgets and birth control apps is making waves. High-end fitness watches from a major brand now share nightly skin temperature data with a fertility app approved by health regulators. The idea is simple: cooler skin at night can hint at ovulation timing, helping use
The FDA has introduced a new program that promises super-fast drug approvals. This program, called the Commissioner’s National Priority Voucher, can approve drugs in just one to two months. This is much faster than the usual 10-month review process. The idea is to prioritize drugs that match certain
A device approved by the FDA for treating ADHD in children has been found ineffective in a recent clinical trial. The external trigeminal nerve stimulator, which was expected to reduce ADHD symptoms, showed no significant improvement compared to a placebo. The FDA had initially approved the device
The U. S. Food and Drug Administration (FDA) has given the green light to a new drug called Nereus, designed to tackle motion sickness. This approval is a big deal because it's the first new treatment for this condition in over 40 years. The drug, also known as tradipitant, works by blocking a speci
